chevron_leftBack
As of 24 April 2025, Dongwu Cement International Ltd. has a market cap of $149.42M USD, ranking #18664 globally and #385 in Hong Kong. It ranks #1959 in the Basic Materials sector, and #155 in the Building Materials industry.
Key Stats
Market Cap
$149.42MUSD
1.16B HKD
Enterprise Value
$155.58MUSD
1.21B HKD
Revenue (TTM)
$28.82MUSD
223.6M HKD
EBITDA (TTM)
-$3.12MUSD
-24.22M HKD
Net Income (TTM)
-$8.9MUSD
-69.05M HKD
EBITDA Margin
-11%
Profit Margin
-31%
Company Profile
Country (HQ)
Sector
Basic Materials
Industry
Building Materials
CEO
Junxian Wu
open_in_new
Employees
282
Founded
2011
Website
dongwucement.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 4.8% | -7.5% | -2.8% | -22% | 20% | 14% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
695
东吴水泥国际有限公司
ISIN: KYG281601024
Shares Out.:
Shares Outstanding:
552.0M1
Shares Float:
183.91M2
|
2.20 HKD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Dongwu Cement International Ltd.
Dongwu Cement International Limited, an investment holding company, engages in production and sale of cement under the Dongwu brand name in the People’s Republic of China. The company operates through Production and Sale of Cement; Research and Development in Biotechnology; Production and Sale of Magnetic Materials and Other Application Products; and Trading Business segments. It offers ordinary and composite Portland cement, as well as clinker as a by-product; sells motor machines and parts, rare earth materials, metals, and anode materials and oxides; and electroplating and processing, and calcination services. The company is also involved in the sewage and sludge treatment activities; science and technology investment business; investment management and consultation activities; and production and sale of magnetic materials and other application products. In addition, it engages in the research and development of biotechnology; and research, development, and commercialization of medicines and therapies for cancers and autoimmune diseases. The company was incorporated in 2011 and is headquartered in Suzhou, China. Dongwu Cement International Limited operates as a subsidiary of Goldview Development Limited.
